News Focus
News Focus
icon url

DewDiligence

01/13/20 7:47 PM

#228230 RE: DewDiligence #226553

MRK CEO on JPM webcast: Keytruda and Gardasil will continue strong growth in China even without inclusion in the NDRL (government reimbursement) list. Gardasil sales (worldwide) are constrained by production capacity, not demand.
icon url

DewDiligence

02/05/20 8:49 AM

#228508 RE: DewDiligence #226553

MRK 4Q19 results/2020 guidance…

PR:
https://finance.yahoo.com/news/merck-announces-fourth-quarter-full-114700713.html

CC slides (including spinoff info):
https://s21.q4cdn.com/488056881/files/doc_financials/2019/q4/4Q19-Earnings-Deck_MRK.pdf

--
2020 non-GAAP EPS guidance is $5.62-5.77, +8% to +11% YoY.